Dow Up 1.30% Nasdaq Up 0.37%

Vertex Pharmaceuticals Incorporated (VRTX)

-NasdaqGS
110.85 0.94(0.86%) Oct 30, 4:00PM EDT
Prev Close:109.91
Open:109.21
Bid:106.79 x 100
Ask:115.00 x 500
1y Target Est:115.50
Beta:-0.97
Earnings Date:Jan 27 - Feb 2 (Est.)
Day's Range:108.61 - 111.82
52wk Range:58.06 - 116.88
Volume:1,398,361
Avg Vol (3m):1,666,400
Market Cap:26.18B
P/E (ttm):N/A
EPS (ttm):-2.22
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
VRTXUp 0.86%26.18B
BMY97.83B
MRK165.32B
PTCT1.20B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):32.98
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.98
Quarterly EPS Est (Sep-14) :-0.62
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):-1.96

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Vertex Pharmaceuticals Incorporated is engaged in discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback